Moat Ross sold KNSA
April 1, 2026 · Form 4 insider transaction
Moat Ross sold 1,706 shares of Kiniksa Pharmaceuticals International, plc at $48.13 per share, a transaction worth $82.1K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,706
Price
$48.13
Total value
$82.1K
InsiderMoat Ross
RoleOfficer
SecurityClass A Ordinary Share
Transaction codeF: Shares withheld for taxes
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after14,396
OwnershipDirect
10b5-1 planNo
AmendedNo